The scientist’s investigation covers issues in Immunology, Virology, Malaria, Immunity and Immune system. As part of the same scientific family, Michael F. Good usually focuses on Immunology, concentrating on Cytotoxic T cell and intersecting with Immunotherapy. His Virology study integrates concerns from other disciplines, such as Malaria vaccine, Epitope, Antibody, Antigen and Microbiology.
His Malaria research incorporates themes from Intensive care medicine, Disease and Vaccination. In his research on the topic of Immunity, Monoclonal antibody is strongly related with PfSPZ vaccine. His Immune system study incorporates themes from Plasmodium falciparum, Cerebral Malaria and Plasmodium yoelii.
Michael F. Good mainly investigates Immunology, Virology, Epitope, Antibody and Malaria. His Immunology study which covers Cytotoxic T cell that intersects with CD8 and T lymphocyte. His Virology research includes elements of Peptide vaccine, Immunization, Antigen, Plasmodium falciparum and Plasmodium yoelii.
His Epitope research is multidisciplinary, incorporating elements of Adjuvant, Lipopeptide, Peptide and Immunogenicity. The Antibody study combines topics in areas such as Molecular biology and Microbiology. His biological study spans a wide range of topics, including Cellular immunity, Disease and Intensive care medicine.
Michael F. Good spends much of his time researching Immunology, Virology, Immune system, Malaria and Antibody. Many of his research projects under Immunology are closely connected to Streptococcal Vaccines with Streptococcal Vaccines, tying the diverse disciplines of science together. Michael F. Good has included themes like Epitope, Peptide vaccine, Plasmodium falciparum and Virulence in his Virology study.
The study incorporates disciplines such as Parasitemia, Cytokine and Antigen in addition to Immune system. His work on Malaria vaccine, Plasmodium and Blood stage as part of general Malaria study is frequently connected to Biological sciences, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Antibody is closely attributed to Microbiology in his research.
Michael F. Good focuses on Immunology, Virology, Immune system, Malaria and Microbiology. In the field of Immunology, his study on Vaccination, Rheumatic fever and Cellular immunity overlaps with subjects such as Streptococcal Vaccines. The concepts of his Virology study are interwoven with issues in Streptococcus, Parasitology and Virulence.
His Immune system research is multidisciplinary, incorporating perspectives in Antigen and Plasmodium vivax. His study in Malaria is interdisciplinary in nature, drawing from both Medical microbiology, Ex vivo and Efficacy. His research in Microbiology intersects with topics in Antibody, Nasal administration and Peptide vaccine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites
Walter R. Weiss;Martha Sedegah;Richard L. Beaudoin;Louis H. Miller.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.
David J Pombo;David J Pombo;Gregor Lawrence;Chakrit Hirunpetcharat;Christine Rzepczyk.
The Lancet (2002)
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
MF Good;WL Maloy;MN Lunde;H Margalit.
Immune effector mechanisms in malaria.
Michael F Good;Denise L Doolan.
Current Opinion in Immunology (1999)
Malaria vaccine developments.
Vasee S. Moorthy;Michael F. Good;Adrian V.S. Hill.
The Lancet (2004)
Research toward malaria vaccines.
Louis H. Miller;Russell J. Howard;Richard Carter;Michael F. Good.
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.
W R Weiss;S Mellouk;R A Houghten;M Sedegah.
Journal of Experimental Medicine (1990)
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research
Michael Francis Good;Huji Xu;Michelle Wykes;Christian R. Engwerda.
Annual Review of Immunology (2005)
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.
M F Good;J A Berzofsky;W L Maloy;Y Hayashi.
Journal of Experimental Medicine (1986)
PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINE*
Michael F. Good;David C. Kaslow;Louis H. Miller.
Annual Review of Immunology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: